CorMedix Inc. is a biopharmaceutical company that develops and commercializes therapeutic products for infectious and inflammatory diseases worldwide. DefenCath/Neutrolin is the company's lead product candidate, designed to prevent catheter-related infections and thrombosis for patients with central venous catheters. CorMedix Inc. was established in 2006, operates out of Berkeley Heights, New Jersey, and was previously known as Picton Holding Company, Inc.